Potent, reversible, cell-permeable inhibitor that specifically inhibits the 19S regulatory particle- associated deubiquitinases. b-AP15 has been shown to inhibit tumor progression in at least four solid tumor models, and also inhibits organ infiltration in an acute myeloid leukemia (AML) model. b-AP15 is made available through collaboration with Vivolux AB, Uppsala, Sweden.